Recent vitiligo research has challenged long-held assumptions about skin cancer risk in patients with depigmented lesions. A ...

Migraine and cluster headache autoinjector treatment Brekiya (dihydroergotamine mesylate) is now available by prescription through Walgreens Specialty Pharmacy and Sterling Specia ...

When equipped with real-time data and integrated into the care team, pharmacists and pharmacy benefit managers can proactively identify health risks, support care coordination, and close medication ...

Type A botulinum, commonly reffered to as botox, was approved by FDA in 2002 for cosmetic use to reduce fine lines and ...

In this first segment from an interview with Managed Healthcare Executive about his presentation about trends in aesthetic ...

Fifty-four percent of patients ages 12 to 18 with severe alopecia noticed hair regrowth when given 4-mg of Olumiant (oral baricitinib), according to results of a study presented this week at the 2025 ...

In the VALOR trial, brepocitinib 30 mg demonstrated clinically meaningful and statistically significant improvement compared ...

Nearly 1 in 10 U.S. adults report having physician-diagnosed chronic head eczema, according to findings from a ...

The use of interleukin (IL)-23 inhibitors plays an important role in treating patients with psoriasis, as well as in treating ...

Unlike existing treatments that block individual cytokines such as IL-4, IL-13 or IL-31, therapies targeting the OX40 pathway ...

Eichenfield said that depending on severity, atopic dermatitis treatment is begun right away in these younger patients ...

Expensive, newer therapies and a lack of pediatric data are roadblocks to advancing treatment for pediatric atopic dermatitis ...